China Sky One Medical, Inc. Appoints Yu-bo ...( HARBIN China Dec. 2 Asia-FirstCall/ -...),Health

HARBIN, China, Dec. 2 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), announced today that Mr. Yu-bo (Stanley) Hao was appointed Chief Financial Officer and Secretary and will also serve on the Company's Board of Directors. He replaces Yu-kun Zhang, who had served as interim CFO since June, 2008. Mr. Zhang is staying on as Finance and Accounting Manager.

Mr. Hao has been employed at China Sky One in various capacities since June, 2008. From January, 2006, to March, 2008, he served as President's Assistant and Financial Officer for Sumitomo Group Canadian Branch. Prior to Sumitomo, Mr. Hao served as Marketing Executive and Canadian Market Analyst for MGM Mirage from September, 2004, to December, 2005. From September, 1997, to October, 2001, he was co-founder and CEO of SunnyZone Consulting Co. Ltd. Mr. Hao holds a Bachelor's degree in Economics & Arts from Beijing Union University and an MBA from the University of Phoenix.

"We are very pleased to announce the appointment of Stanley Hao as the CFO of China Sky One. Over the past several months Mr. Hao has worked closely with our finance and accounting team to ensure that our company is able to meet our financial reporting requirements as a U.S.-listed public company, and provide transparent and effective communications with our global shareholder base," said Mr. Yan-qing Liu, Chairman, CEO and Director of China Sky One Medical, Inc. "Our company is committed to continuing to build a robust accounting and finance function to support our rapid growth and ensure timely and accurate reporting to our shareholders."

"I am honored to be appo
'/>"/>